ADIPOQ (adiponectin, C1Q and collagen domain containing; HGNC:13633, NCBI Gene 9370) is the gene on chromosome 3q27.3 encoding adiponectin — the adipocyte hormone of the collagen-like and C1q-domain family whose plasma levels (paradoxically falling with obesity) sensitize liver and muscle to insulin and restrain atherosclerosis. The adiponectin hormone page is the canonical physiology reference; the protein page holds the structure.
Approved Symbol
ADIPOQ (HGNC:13633)
Chromosomal Locus
3q27.3
Encoded Product
Adiponectin — a 30-kDa adipokine (244 aa) forming trimers to high-molecular-weight multimers
3q27 metabolic-syndrome linkage; the inverse-obesity paradox; adiponectin-agonist research
Gene Structure & Expression
Genomic organization: Three exons (signal peptide, collagen domain, globular C1q head); the promoter carrying PPARγ-response elements (thiazolidinediones raise adiponectin via PPARγ — the glitazones' insulin sensitization mechanism).
Expression: Adipocytes only — the most abundant adipose-specific transcript, yet its circulating level falls as fat mass rises (the obesity paradox: insulin resistance's adiponectin deficiency).
Molecular Function & Pathways
Receptor signaling: AdipoR1 (ubiquitous, the globular-domain receptor) activating AMPK — fatty-acid oxidation and glucose use up; AdipoR2 (liver) via PPARα; multimer size determining receptor preference, see the insulin-signaling context it complements.
Vascular and anti-inflammatory: NO-dependent vasodilation, macrophage foam-cell suppression, and anti-atherogenic action — the adipose tissue's protective messenger, opposite LEP-leptin's rising-with-fat pattern.
Clinical & Therapeutic Significance
Clinical genetics: The 3q27 locus's original metabolic-syndrome linkage; rare ADIPOQ mutations with extreme insulin resistance and lipodystrophy overlap; hypoadiponectinemia as cardiometabolic risk marker.
Therapeutic attempts: Recombinant adiponectin and AdipoR agonists (adiporon) still preclinical — the biomarker easier than the drug; lifestyle and thiazolidinedione-adjacent interventions that raise adiponectin remain the practical route; the 3q27 GWAS signal's cardiometabolic associations.